Ecolab (NYSE:ECL) in our automated value investing analysis, with the cash flow history and price comparison below.
Advertisement helps keep Trendshare free for most readers.
Estimate how long you need to hold Ecolab to reach your target.
Based on historical returns, we believe that Ecolab can grow its free cash at a rate of about 6%. That's positive!
| Advantages | Disadvantages |
|---|---|
|
|
| ECL Price (Ecolab stock price per share) |
$294.70 | |
|
|
ECL Fair Price (based on intrinsic value) |
$161.90 |
| ECL Safety Price (based on a variable margin of safety) | $129.52 | |
|
Try your own return
The fair price above uses a 10.1% discount rate, the long-run US stock return (10.1% geometric, 1926 to 2025, from Bessembinder's working paper, updated 2026-11-09), and 2.5% terminal growth. A higher rate suits a higher return target and gives a lower value. Value per share: |
||
| PE Ratio versus Sector | 188% higher than other Consumer Defensive stocks | |
| PE Ratio versus Industry | 23% higher than other Household & Personal Products stocks | |
| Cash Yield | 2.47% | |
| Free Cash Flow Jitter | 21% | |
| Dividend Yield | 0.98% (tax impact) | Shares Shorted | 4,246,010 |
No open-market insider buys or sells are recorded for the last 12 months.
This stock has short interest! This means that people have shorted it.
Why does that matter? They've made a bet that price will decrease from where they bought it. Maybe there are financial problems, or maybe there's a value play.
As of the latest analysis, there are 4,246,010 shares shorted. With 279,864,779 shares available for purchase and an average trading volume over the past 10 trading days of 1,489,920, it would take at least 2.8 days for all of the short holders to cover their shorts.
Related guides: good annual rate of return · high-yield stocks · forecasting earnings growth
How to read this: free cash flow in plain terms, free cash flow jitter.
Each year names the SEC filer that reported it, so a change of filer shows up here.
| Fiscal year | SEC filer (CIK) | Free cash flow (USD millions) |
|---|---|---|
| 2007 | 31462 | 491 |
| 2008 | 31462 | 403 |
| 2009 | 31462 | 362 |
| 2010 | 31462 | 626 |
| 2011 | 31462 | 353 |
| 2012 | 31462 | 810 |
| 2013 | 31462 | 1,121 |
| 2014 | 31462 | 1,287 |
| 2015 | 31462 | 1,376 |
| 2016 | 31462 | 1,238 |
| 2017 | 31462 | 1,337 |
| 2018 | 31462 | 1,493 |
| 2019 | 31462 | 1,639 |
| 2020 | 31462 | 1,135 |
| 2021 | 31462 | 1,360 |
| 2022 | 31462 | 1,117 |
| 2023 | 31462 | 1,742 |
| 2024 | 31462 | 2,091 |
| 2025 | 31462 | 2,118 |
Download the yearly data as CSV.
How to read this: what free cash flow is, why earnings matter.
Over the 9 fiscal years from 2007 to 2025 with positive net income, operating cash flow totaled $15,225 million against net income of $9,605 million, or 1.59 times.
In 2025, operating cash flow was 1.42 times net income, compared with 1.74 times for the earliest three years (2007 to 2009).
In 2025, capital expenditures were $1,048 million, 35.5% of operating cash flow of $2,953 million, which leaves an estimated $1,904 million after capex. Across the 9 years with reported capex, it averaged 35.9% of operating cash flow. This uses that year's own capital expenditures, not the five-year average behind the free cash flow table, so the two can differ.
Cash conversion in 2025 was 1.42, at least 0.25 under the 1.74 earliest three-year ratio. Gaps like this come from non-cash gains or from cash tied up in receivables, inventory or other working capital.
| Fiscal year | Net income (USD millions) | Operating cash flow (USD millions) | Capital expenditures (USD millions) | Operating cash flow / net income |
|---|---|---|---|---|
| 2007 | 427 | 798 | 307 | 1.87 |
| 2008 | 448 | 753 | 395 | 1.68 |
| 2009 | 417 | 695 | 297 | 1.67 |
| 2010 | 530 | 950 | 298 | 1.79 |
| 2021 | 1,130 | 2,062 | 643 | 1.82 |
| 2022 | 1,092 | 1,788 | 713 | 1.64 |
| 2023 | 1,372 | 2,412 | 775 | 1.76 |
| 2024 | 2,112 | 2,814 | 995 | 1.33 |
| 2025 | 2,076 | 2,953 | 1,048 | 1.42 |
How to read this: why companies buy back shares, dividend yield explained.
Over the 10 fiscal years from 2016 to 2025 with dividend or share repurchase facts, estimated free cash flow totaled $15,271 million. That estimate uses the average of up to five years of capital expenditures, not each year's own, so it is not a reported figure.
In the 10 of those years with dividend payment facts, dividends paid totaled $5,689 million, 37.3% of the estimated free cash flow of those years. Estimated free cash flow was at least the dividends paid in 10 of those 10 years.
In 9 of the 10 years, cash spent repurchasing shares was at least 5% of that year's estimated free cash flow, and in those years it totaled $4,797 million. Smaller amounts are left out of this sentence because they can be shares withheld to pay employees' taxes on stock awards.
In 2025, dividends and cash spent repurchasing shares together were $1,537 million, 72.6% of estimated free cash flow of $2,118 million.
| Fiscal year | Estimated free cash flow (USD millions) | Dividends paid (USD millions) | Cash spent repurchasing shares (USD millions) | Total returned (USD millions) | Total as a percent of estimated free cash flow |
|---|---|---|---|---|---|
| 2016 | 1,238 | 428 | 740 | 1,167 | 94.3% |
| 2017 | 1,337 | 449 | 600 | 1,049 | 78.4% |
| 2018 | 1,493 | 495 | 562 | 1,057 | 70.8% |
| 2019 | 1,639 | 553 | 354 | 907 | 55.3% |
| 2020 | 1,135 | 561 | 146 | 707 | 62.3% |
| 2021 | 1,360 | 566 | 107 | 673 | 49.5% |
| 2022 | 1,117 | 603 | 518 | 1,121 | 100.3% |
| 2023 | 1,742 | 617 | 13.7 | 631 | 36.2% |
| 2024 | 2,091 | 664 | 987 | 1,651 | 78.9% |
| 2025 | 2,118 | 754 | 784 | 1,537 | 72.6% |
Free cash flow here is an estimate: operating cash flow less the average of up to five years of capital expenditures. Cash spent repurchasing shares can include shares withheld to pay employees' taxes on stock awards. The entry n/a means the filings gave no usable figure, not that the amount was zero. Source: the company's annual reports to the SEC.
How to read this: earnings and margins.
Revenue was $5,470 million in 2007 and $16,081 million in 2025, a compound annual growth rate of 6.2% over 18 years.
Revenue rose 2.2% from 2024 to 2025.
Our estimated free cash flow was $2,118 million in 2025, 13.2% of revenue. In 2007 the estimated margin was 9.0%. This estimate charges each year with the average of up to five years of capital expenditures, so it is not the free cash flow the company reported.
| Fiscal year | Revenue (USD millions) | Estimated free cash flow (USD millions) | Estimated free cash flow / revenue |
|---|---|---|---|
| 2007 | 5,470 | 491 | 9.0% |
| 2008 | 6,138 | 403 | 6.6% |
| 2009 | 5,901 | 362 | 6.1% |
| 2010 | 6,090 | 626 | 10.3% |
| 2011 | 6,799 | 353 | 5.2% |
| 2012 | 11,839 | 810 | 6.8% |
| 2013 | 13,253 | 1,121 | 8.5% |
| 2014 | 14,281 | 1,287 | 9.0% |
| 2015 | 13,545 | 1,376 | 10.2% |
| 2016 | 13,153 | 1,238 | 9.4% |
| 2017 | 13,838 | 1,337 | 9.7% |
| 2018 | 12,222 | 1,493 | 12.2% |
| 2019 | 12,562 | 1,639 | 13.1% |
| 2020 | 11,790 | 1,135 | 9.6% |
| 2021 | 12,733 | 1,360 | 10.7% |
| 2022 | 14,188 | 1,117 | 7.9% |
| 2023 | 15,320 | 1,742 | 11.4% |
| 2024 | 15,741 | 2,091 | 13.3% |
| 2025 | 16,081 | 2,118 | 13.2% |
How to read this: how debt and assets are compared, the current ratio.
In 2025, cash and equivalents were $646 million against total liabilities of $14,892 million, or 4.3% of total liabilities. Total liabilities include everything the company owes, not only borrowed money.
Total liabilities were 60.3% of total assets in 2025, compared with 66.8% in 2008, a decrease of 6.5 percentage points.
Stockholders equity was $9,805 million in 2025, compared with $1,579 million in 2008, a rise of 520.9%.
Based on our estimated free cash flow, cash flow return on invested capital (CROIC) was 11.4% in 2025. Invested capital here is total assets less cash and current liabilities.
| Fiscal year | Total assets (USD millions) | Cash and equivalents (USD millions) | Total liabilities (USD millions) | Stockholders equity (USD millions) |
|---|---|---|---|---|
| 2008 | 4,757 | 66.7 | 3,178 | 1,579 |
| 2009 | 5,021 | 73.6 | 3,011 | 2,010 |
| 2010 | 4,872 | 242 | 2,739 | 2,133 |
| 2011 | 18,185 | 1,844 | 12,444 | 5,741 |
| 2012 | 17,572 | 1,158 | 11,412 | 6,160 |
| 2013 | 19,637 | 339 | 12,227 | 7,409 |
| 2014 | 19,427 | 210 | 12,045 | 7,382 |
| 2015 | 18,642 | 92.8 | 11,661 | 6,980 |
| 2016 | 18,330 | 327 | 11,389 | 6,971 |
| 2017 | 19,964 | 211 | 12,310 | 7,654 |
| 2018 | 20,075 | 115 | 12,021 | 8,054 |
| 2019 | 20,869 | 119 | 12,143 | 8,726 |
| 2020 | 18,126 | 1,260 | 11,925 | 6,202 |
| 2021 | 21,206 | 360 | 13,953 | 7,253 |
| 2022 | 21,464 | 599 | 14,206 | 7,259 |
| 2023 | 21,847 | 920 | 13,774 | 8,072 |
| 2024 | 22,388 | 1,257 | 13,599 | 8,789 |
| 2025 | 24,696 | 646 | 14,892 | 9,805 |
How to read this: discounted cash flow, intrinsic value.
At today's price of $294.70, our model's value equals that price if free cash flow grows an average of 15.6 percent a year over the 10 projection years. Our model assumes 5.9 percent a year for this stock, so the price implies growth of 15.6 percent, which is above the 5.9 percent our model assumes. This is the growth the price implies under our model, not a forecast of growth or a price target.
The table shows the same calculation at a price 20 percent lower and 20 percent higher than today's price, and the model's own growth rate at its fair price.
The model starts from the company's average free cash flow of $2,045 million, grows it over 10 years along the year-by-year growth path stored for this stock (the pace fades over the years, and the implied rate keeps that shape, so the rates here are 10-year averages), discounts it at 10.1 percent a year, adds a terminal value that grows 2.5 percent a year after year 10, adds the company's net worth, and divides by shares outstanding.
The baseline is the company's average free cash flow, and cyclical companies can mislead it.
| Case | Price per share | Average annual free cash flow growth |
|---|---|---|
| 20 percent below the current price | $235.76 | 12.1% |
| Current price | $294.70 | 15.6% |
| 20 percent above the current price | $353.64 | 18.4% |
| Our model (stored fair price) | $161.90 | 5.9% |
Model assumptions: 10.1 percent discount rate, 2.5 percent terminal growth, 10 projection years. To try your own growth rate, use the intrinsic value calculator on this page. It uses a simpler single-rate model, so its results will not match the figures above exactly.
Every one of the 19 fiscal years we have for Ecolab under its current filer shows positive free cash flow.
At $294.70, Ecolab trades above our fair value estimate of $161.90.
Comparing the first and last three years of data, average free cash flow rose sharply: $419 million at the start and $1,984 million most recently.
Year-to-year variability in free cash flow is fairly steady, measured at 21%.
Its dividend yield is 0.98%.
Our value investing guide explains how to test these numbers against the filings themselves.
How to read this: the price to earnings ratio.
Its trailing P/E ratio is 188% above the average for stocks in the Consumer Defensive sector.
Its trailing P/E ratio is 23% above the average for stocks in the Household & Personal Products industry.
A P/E ratio depends on trailing earnings, which one-time items can distort, so a lower P/E is not by itself evidence of value.
These are companies in the Household & Personal Products industry, the ones closest in market capitalization to Ecolab, limited to companies whose pages we publish. The figures come from our latest data for each company.
| Company | Market cap (USD millions) | P/E | Dividend yield | Cash yield | Price versus our estimate |
|---|---|---|---|---|---|
| Ecolab (ECL) | 82,654 | 40.1 | 1.0% | 2.5% | 82% above |
| Colgate-Palmolive Company (CL) | 78,467 | 38.4 | 2.2% | 3.5% | 41% below |
| The Estee Lauder Companies (EL) | 36,037 | 99.5 | 1.4% | 5.2% | 61% below |
| Church & Dwight Co. (CHD) | 26,162 | 34.0 | 1.1% | 2.5% | 42% above |
| Coty (COTY) | 3,481 | - | - | - | 17% above |
| United-Guardian (UG) | 32.8 | 10.5 | 2.0% | - | 193% above |
| The Procter & Gamble Company (PG) | 389,040 | 24.9 | 2.5% | 3.6% | 7% above |
Industry labels are approximate, and companies in one industry can run quite different businesses, so a peer may not be a close match.
Ratios on different fiscal calendars are not strictly comparable, and a trailing P/E can be distorted by one-time items.
Every fiscal year on this page is reported by one SEC filer, CIK 31462.
Each figure on this page comes from that filer.
How to read this: understanding investment risk.
Company figures come from the annual reports (Form 10-K) that each company files with the SEC, read from the SEC EDGAR company facts data. The share price and other market data come from a market data provider.
Free cash flow here is operating cash flow minus capital spending. To keep one unusual year from swinging the result, each year is charged with the average of up to five years of capital spending, so the figure is an estimate and not the free cash flow a company reports.
The fair price is the present value of ten years of projected free cash flow plus a terminal value, discounted at 10.1 percent a year, the long-run return of US stocks, with 2.5 percent growth after year ten. The figures on this page are estimates, not advice.
This analysis covers US companies that file 10-K annual reports. Free cash flow describes banks, real estate investment trusts and funds poorly, so treat their figures with extra caution. In the cash returned and balance sheet tables, a value of zero is treated as a gap in the data, not as a real zero.
Read the filings yourself: ECL annual reports (10-K) on SEC EDGAR. To try your own growth rate, use the intrinsic value calculator on this page. Our editorial standards explain how Trendshare handles its sources and corrections.
Advertisement supports free stock analysis content.
Does Ecolab have a coherent story? Does it have a plan to continue to make money? Is it worth your time? Only you can decide where to go from here. Our investment guide helps you ask the right questions, including how to buy stocks. Use these research links for more information.
This example shows how we apply the Trendshare checklist to ECL: earnings power, cash generation, valuation, and margin of safety.
We check: business quality, free cash flow, P/E, and margin of safety.
Most Popular Articles
How Does Portfolio Churning Affect Your Returns?
Insider Buying as a Conviction Signal
What is Market Capitalization?
What is Cash Return on Invested Capital?